Fig. 1
From: Risk factors for failing sub-Tenon’s triamcinolone acetonide for uveitic macular edema
Example of an eye with uveitic macular edema that responded well to sub-Tenon’s triamcinolone acetonide (STA) but would not have met criteria for the POINT trial. The initial OCT macula of the left eye shows intra-retinal cystoid spaces with a central subfield thickness of 258 μm (a) and the initial fluorescein angiogram shows petaloid macular leakage (b). Two months following STA, the intra-retinal cystoid spaces (c) and petaloid macular leakage (d) have resolved